To investigate whether these RELA-binding sites play critical roles in CD271 function and cancer malignancy (especially cancer stem cell-related phenotypes), we performed a sphere-forming assay using cells harboring mutations of RELA-binding sites in the CD271 promoter. The gene discussed is RELA; the disease is cancer.